Image
SumanSpeaks Independent Capital Markets & Geopolitical Intelligence  |  Estd 2006 Corporate Strategy  |  AI Pivot & Power Infrastructure Reliance Power's AI Pivot (₹25.10): Rebranding, ₹9,000 Cr Capital, and a Policy Tailwind Arriving Right on Cue Four renamed subsidiaries. A ₹9,000 crore fundraise. And a state government simultaneously building the exact demand this pivot is betting on. On June 30, 2026, Reliance Power quietly filed one of the more consequential corporate-identity shifts in the Indian power sector this year. Four of its subsidiaries were renamed Reliance AI Green Power, Reliance AI Power, Reliance AI Data Control, and Reliance AI Data C — and the company formally added artificial intelligence and technology-enabled services to its business objects. This was not a data-centre announcement or a customer contract. It was...
Tit - bits
#The BSE Sensex is now seen at 41,425.75 or
Photo: Seeking Alpha 
down just 99.75  points (-0.25%) while NSE's Nifty is trading at 12,196.55 or down only 25.40 points (-0.23%). This is much improvement from the level when the Sensex nosedived 200 - points. 
Market sentiment was affected by the fact that  International Monetary Fund (IMF) loweried India's growth forecast, apart from subdued quarterly results by key index constituents and negative global cues.
However,  what the market missed is that IMF on 20 January also said global growth, estimated at 2.9% in 2019, is projected to increase to 3.3% in 2020 and inch up further to 3.4% in 2021 -- which means growth would continue though a tad below the estimates. This is positive for the BULLS. 
For India too,  the outlook looks much better in CY2020 than for FY20, as per the IMF commentary, which said: India's growth is estimated at 4.8% in 2019, projected to improve to 5.8% in 2020 and 6.5% in 2021 (1.2% and 0.9% lower than the October forecast), supported by monetary and fiscal stimulus as well as subdued oil prices. 
Therefore, I feel the investors should use every opportunity to buy good stocks in situations like today,  to reap superb benefits in the short to medium term.

#Buy the shares of Strides Parma Science Ltd at the CMP of Rs.390.40, for short term targets of Rs. 415/417. SL: Rs.382.
The company recently announced successful closure of the US drug regulator's inspection at its manufacturing site in Florida, United States.

Comments

Popular posts from this blog